AFP11 時間
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Pilot News2 時間
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...
Le Lézard19 時間
Vertex Announces FDA Approval of JOURNAVXtm (suzetrigine), a First-in-Class Treatment for ...
Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVXtm (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal ...